Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

849 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perspectives on the management of hypertension in Japan.
Maruhashi T, Kihara Y, Higashi Y. Maruhashi T, et al. Among authors: kihara y. Expert Opin Pharmacother. 2020 Jul;21(10):1179-1187. doi: 10.1080/14656566.2020.1724958. Epub 2020 Feb 8. Expert Opin Pharmacother. 2020. PMID: 32037893 Review.
Endothelial Function Is Impaired in Patients Receiving Antihypertensive Drug Treatment Regardless of Blood Pressure Level: FMD-J Study (Flow-Mediated Dilation Japan).
Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Aibara Y, Yusoff FBM, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y. Maruhashi T, et al. Among authors: kihara y. Hypertension. 2017 Oct;70(4):790-797. doi: 10.1161/HYPERTENSIONAHA.117.09612. Epub 2017 Aug 14. Hypertension. 2017. PMID: 28808069 Clinical Trial.
Relationship between home blood pressure and vascular function in patients receiving antihypertensive drug treatment.
Maruhashi T, Kinoshita Y, Kajikawa M, Kishimoto S, Matsui S, Hashimoto H, Takaeko Y, Aibara Y, Yusoff FM, Hidaka T, Chayama K, Noma K, Nakashima A, Goto C, Takahashi M, Kihara Y, Higashi Y; Hiroshima NOCTURNE Research Group. Maruhashi T, et al. Among authors: kihara y. Hypertens Res. 2019 Aug;42(8):1175-1185. doi: 10.1038/s41440-019-0240-8. Epub 2019 Mar 7. Hypertens Res. 2019. PMID: 30846869
Relationships Between Calcium Channel Blockers and Vascular Function Tests.
Maruhashi T, Kajikawa M, Kishimoto S, Matsui S, Hashimoto H, Takaeko Y, Aibara Y, Yusoff FM, Hidaka T, Chayama K, Noma K, Nakashima A, Goto C, Kihara Y, Higashi Y. Maruhashi T, et al. Among authors: kihara y. Am J Hypertens. 2019 Jun 11;32(7):640-648. doi: 10.1093/ajh/hpz061. Am J Hypertens. 2019. PMID: 31089726
Increased arterial stiffness and cardiovascular risk prediction in controlled hypertensive patients with coronary artery disease: post hoc analysis of FMD-J (Flow-mediated Dilation Japan) Study A.
Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Iwamoto A, Kajikawa M, Matsumoto T, Oda N, Kishimoto S, Matsui S, Hashimoto H, Takaeko Y, Yamaji T, Harada T, Han Y, Aibara Y, Mohamad Yusoff F, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Kohro T, Suzuki T, Ishizu T, Ueda S, Yamazaki T, Furumoto T, Kario K, Inoue T, Koba S, Watanabe K, Takemoto Y, Hano T, Sata M, Ishibashi Y, Node K, Maemura K, Ohya Y, Furukawa T, Ito H, Ikeda H, Yamashina A, Higashi Y. Maruhashi T, et al. Among authors: kihara y. Hypertens Res. 2020 Aug;43(8):781-790. doi: 10.1038/s41440-020-0420-6. Epub 2020 Mar 9. Hypertens Res. 2020. PMID: 32152482
Calcium channel blocker and Rho-associated kinase activity in patients with hypertension.
Hata T, Soga J, Hidaka T, Idei N, Fujii Y, Fujimura N, Mikami S, Maruhashi T, Kihara Y, Chayama K, Kato H, Noma K, Liao JK, Higashi Y; ROCK Study Group. Hata T, et al. Among authors: kihara y. J Hypertens. 2011 Feb;29(2):373-9. doi: 10.1097/HJH.0b013e328340902d. J Hypertens. 2011. PMID: 21063203 Free PMC article. Clinical Trial.
Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension.
Fujimura N, Noma K, Hata T, Soga J, Hidaka T, Idei N, Fujii Y, Mikami S, Maruhashi T, Iwamoto Y, Kihara Y, Chayama K, Kato H, Liao JK, Higashi Y; ROCK Study Group. Fujimura N, et al. Among authors: kihara y. Clin Pharmacol Ther. 2012 Feb;91(2):289-97. doi: 10.1038/clpt.2011.227. Epub 2011 Dec 28. Clin Pharmacol Ther. 2012. PMID: 22205191 Free PMC article. Clinical Trial.
849 results